BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Lung
,
Holistic medicine
,
Rapamycin
,
rs2300478
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Mec 3
Summary
General Info
Curated Studies
Most Correlated Studies
Developmental roles of MEC and NuRD complexes in Caenorhabditis elegans
Identification of genes expressed in C. elegans touch receptor neurons
Comparison of different cell subpopulations of the normal human breast
Mammary stem/basal cells with PYGO2 conditional knockout
Regulatory T cells derived from embryonic or adult hematopoeitic stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
The PDLIM family of actin-associated proteins and their emerging role in membrane trafficking.
MBL-1 and EEL-1 affect the splicing and protein levels of MEC-3 to control dendrite complexity.
Deficient mechanosensation in mec-3 decreases precipice response in C. elegans.
The trxG protein ULT1 regulates Arabidopsis organ size by interacting with TCP14/15 to antagonize th…
MICAL-like1 in endosomal signaling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Mye…
Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ